CAL
GBIO

Capital Advisors Ltd’s Generation Bio GBIO Stock Holding History

Capital Advisors Ltd’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed – – 1453
2024
Q3 		$0 Sell
3
-1
-25% -$26 ﹤0.01% 1466
2024
Q2 		$0 Hold
4
– – ﹤0.01% 1483
2024
Q1 		$0 Buy
+4
New +$94 ﹤0.01% 1428
2022
Q4 		– Sell
-4
Closed – – 1362
2022
Q3 		$0 Buy
+4
New +$250 ﹤0.01% 1323
2022
Q2 		– Sell
-1
Closed – – 1111
2022
Q1 		$0 Buy
+1
New +$58 ﹤0.01% 1015

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital Advisors Ltd's GBIO Position: Q4 2024 in Review

Capital Advisors Ltd sold out of Generation Bio (GBIO) in Q4 2024, closing a stake of 3 shares.

Capital Advisors Ltd first reported a position in GBIO in Q1 2022 and held it in 5 quarters. The position peaked at $0 in Q3 2024. 78 funds tracked by Wall St. Rank hold GBIO as of Q4 2024.

  • Capital Advisors Ltd reported no remaining Generation Bio position as of Q4 2024 after selling out during the quarter.
  • Capital Advisors Ltd sold 3 Generation Bio shares in Q4 2024.
  • Capital Advisors Ltd first reported a position in Generation Bio in Q1 2022 and held it in 5 quarters.
  • Capital Advisors Ltd's Generation Bio position peaked at $0 in Q3 2024.
  • 78 funds tracked by Wall St. Rank held Generation Bio as of Q4 2024.

Based on Capital Advisors Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.